Abstract
Itching is generally known as pruritus. It is a normal reflex and common in the elderly. Aside from causes such as insect stings and contact with certain marine animals, there are other common causes that can be dermatologic, neuropathic, systemic, and psychogenic. The itch reflex is a complex reflex involving separate receptors on sensory neurons that are similar but distinct from pain sensory fibers in the skin. The receptors can be triggered by histamine, G protein receptors, proteases, and toll-like receptors, through TRPV1, TRPV3, and TRPV4 vanilloid receptors on sensory nerves, gastrin, and serotonin, to mention just a few of the stimuli that can trigger itch. The most common of these is histamine. When the skin is inflamed, as histamine is released, it triggers the itch response. In the elderly, chronic itching can interfere with the quality of life. When caused by organ failure or necessary medications such as medications for pain, it offers a quandary – stop the pain medications and increase pain or suffer with chronic itch. This chapter describes the reflex, itching in the elderly, and therapeutic interventions to reduce itch in the elderly.
Keywords
This is a preview of subscription content, log in via an institution.
References
Beauregard S, Gilchrest BA. A survey of skin problems and skin care regimens in the elderly. Arch Dermatol. 1987;123(12):1638–43.
Han L, Dong X. Itch mechanisms and circuits. Annu Rev Biophys. 2014;43:331–55.
Zachariae R, et al. Dermatology life quality index: data from Danish inpatients and outpatients. Acta Derm Venereol. 2000;80(4):272–6.
Jeffry J, Kim S, Chen ZF. Itch signaling in the nervous system. Physiology (Bethesda). 2011;26(4):286–92.
Ward S. Eczema and dry skin in older people: identification and management. Br J Community Nurs. 2005;10(10):453–6.
Norman RA. Xerosis and pruritus in the elderly: recognition and management. Dermatol Ther. 2003;16(3):254–9.
Wang H, Yosipovitch G. New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma. Int J Dermatol. 2010;49(1):1–11.
Bernhard JD. Itch and pruritus: what are they, and how should itches be classified? Dermatol Ther. 2005;18(4):288–91.
Yosipovitch G, Samuel LS. Neuropathic and psychogenic itch. Dermatol Ther. 2008;21(1):32–41.
Kurban MS, Boueiz A, Kibbi AG. Cutaneous manifestations of chronic kidney disease. Clin Dermatol. 2008;26(3):255–64.
Ward JR, Bernhard JD. Willan’s itch and other causes of pruritus in the elderly. Int J Dermatol. 2005;44(4):267–73.
Yosipovitch G, Fleischer A. Itch associated with skin disease: advances in pathophysiology and emerging therapies. Am J Clin Dermatol. 2003;4(9):617–22.
Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet. 2003;361(9358):690–4.
Ramirez-Bermudez J, Espinola-Nadurille M, Loza-Taylor N. Delusional parasitosis in neurological patients. Gen Hosp Psychiatry. 2010;32(3):294–9.
Kuypers DR. Skin problems in chronic kidney disease. Nat Clin Pract Nephrol. 2009;5(3):157–70.
Hosogi M, et al. Bradykinin is a potent pruritogen in atopic dermatitis: a switch from pain to itch. Pain. 2006;126(1–3):16–23.
Ikoma A, et al. The neurobiology of itch. Nat Rev Neurosci. 2006;7(7):535–47.
Basbaum AI, et al. Cellular and molecular mechanisms of pain. Cell. 2009;139(2):267–84.
Ringkamp M, et al. A role for nociceptive, myelinated nerve fibers in itch sensation. J Neurosci. 2011;31(42):14841–9.
Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci. 2001;4(1):72–7.
Patel T, Yosipovitch G. The management of chronic pruritus in the elderly. Skin Therapy Lett. 2010;15(8):5–9.
van Os-Medendorp H, et al. Effectiveness of the nursing programme ‘Coping with itch’: a randomized controlled study in adults with chronic pruritic skin disease. Br J Dermatol. 2007;156(6):1235–44.
Volonte C, Parisi C, Apolloni S. New kid on the block: does histamine get along with inflammation in amyotrophic lateral sclerosis? CNS Neurol Disord Drug Targets. 2015;14:168–75.
Lewis T, Zotterman Y. Vascular reactions of the skin to injury: part VIII. The resistance of the human skin to constant currents, in relation to injury and vascular response. J Physiol. 1927;62(3):280–8.
Simons FE, Simons KJ. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol. 2011;128(6):1139–50 e4.
Hasegawa Y, et al. Intractable itch relieved by 4-phenylbutyrate therapy in patients with progressive familial intrahepatic cholestasis type 1. Orphanet J Rare Dis. 2014;9:89.
Broadbent JL. Observations on histamine-induced pruritus and pain. Br J Pharmacol Chemother. 1955;10(2):183–5.
Davidson S, Giesler GJ. The multiple pathways for itch and their interactions with pain. Trends Neurosci. 2010;33(12):550–8.
Kim BM, et al. Histamine-induced Ca(2+) influx via the PLA(2)/lipoxygenase/TRPV1 pathway in rat sensory neurons. Neurosci Lett. 2004;361(1–3):159–62.
Mobarakeh JI, et al. Role of histamine H(1) receptor in pain perception: a study of the receptor gene knockout mice. Eur J Pharmacol. 2000;391(1–2):81–9.
Rossbach K, et al. The histamine H receptor as a new target for treatment of canine inflammatory skin diseases. Vet Dermatol. 2009;20(5–6):555–61.
Kollmeier A, et al. The histamine H(4) receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects. J Pharmacol Exp Ther. 2014;350(1):181–7.
Ohsawa Y, Hirasawa N. The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC/Nga mice. Allergy. 2012;67(8):1014–22.
Tey HL, Yosipovitch G. Targeted treatment of pruritus: a look into the future. Br J Dermatol. 2011;165(1):5–17.
Thurmond RL, Gelfand EW, Dunford PJ. The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov. 2008;7(1):41–53.
Dong X, et al. A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell. 2001;106(5):619–32.
Lembo PM, et al. Proenkephalin A gene products activate a new family of sensory neuron – specific GPCRs. Nat Neurosci. 2002;5(3):201–9.
Liu Q, et al. Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell. 2009;139(7):1353–65.
Liu Q, et al. Mechanisms of itch evoked by beta-alanine. J Neurosci. 2012;32(42):14532–7.
Han L, et al. A subpopulation of nociceptors specifically linked to itch. Nat Neurosci. 2013;16(2):174–82.
Shelley WB, Arthur RP. Mucunain, the active pruritogenic proteinase of cowhage. Science. 1955;122(3167):469–70.
Sun YG, et al. Cellular basis of itch sensation. Science. 2009;325(5947):1531–4.
Nichols ML, et al. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science. 1999;286(5444):1558–61.
Soh UJ, et al. Signal transduction by protease-activated receptors. Br J Pharmacol. 2010;160(2):191–203.
Zhu WJ, et al. Expression of mRNA for four subtypes of the proteinase-activated receptor in rat dorsal root ganglia. Brain Res. 2005;1041(2):205–11.
Reddy VB, et al. Cathepsin S elicits itch and signals via protease-activated receptors. J Invest Dermatol. 2010;130(5):1468–70.
Reddy VB, et al. Cowhage-evoked itch is mediated by a novel cysteine protease: a ligand of protease-activated receptors. J Neurosci. 2008;28(17):4331–5.
Ratikan JA, et al. Radiation takes its toll. Cancer Lett. 2015;362:122–30.
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801.
Fischer H, et al. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur J Immunol. 2006;36(2):267–77.
Matzinger P. An innate sense of danger. Ann N Y Acad Sci. 2002;961:341–2.
Matzinger P. The danger model: a renewed sense of self. Science. 2002;296(5566):301–5.
Kim SJ, et al. Analysis of cellular and behavioral responses to imiquimod reveals a unique itch pathway in transient receptor potential vanilloid 1 (TRPV1)-expressing neurons. Proc Natl Acad Sci U S A. 2011;108(8):3371–6.
Menendez D, et al. The toll-like receptor gene family is integrated into human DNA damage and p53 networks. PLoS Genet. 2011;7(3):e1001360.
van den Ancker W, et al. Targeting toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation. Cancer Immunol Immunother. 2011;60(1):37–47.
Davenport AP, Maguire JJ. Endothelin. Handb Exp Pharmacol. 2006;176(Pt 1):295–329.
Sin A, et al. The emerging role of endothelin-1 in the pathogenesis of subchondral bone disturbance and osteoarthritis. Osteoarthritis Cartilage. 2015;23(4):516–24.
Kilickesmez KO, et al. Relationship between serum endothelin-1 level and spontaneous reperfusion in patients with acute myocardial infarction. Coron Artery Dis. 2015;26(1):37–41.
Fu J, et al. Glomerular endothelial cell injury and cross talk in diabetic kidney disease. Am J Physiol Renal Physiol. 2015;308(4):F287–97.
Santi D, et al. Therapy of endocrine disease. Effects of chronic use of phosphodiesterase inhibitors on endothelial markers in type 2 diabetes mellitus: a meta-analysis. Eur J Endocrinol. 2015;172(3):R103–14.
Leask A. Getting to the heart of the matter: new insights into cardiac fibrosis. Circ Res. 2015;116(7):1269–76.
Katugampola R, Church MK, Clough GF. The neurogenic vasodilator response to endothelin-1: a study in human skin in vivo. Exp Physiol. 2000;85(6):839–46.
McQueen DS, Noble MA, Bond SM. Endothelin-1 activates ETA receptors to cause reflex scratching in BALB/c mice. Br J Pharmacol. 2007;151(2):278–84.
Liang J, Kawamata T, Ji W. Molecular signaling of pruritus induced by endothelin-1 in mice. Exp Biol Med (Maywood). 2010;235(11):1300–5.
Kido-Nakahara M, et al. Neural peptidase endothelin-converting enzyme 1 regulates endothelin 1-induced pruritus. J Clin Invest. 2014;124(6):2683–95.
Mishra SK, Hoon MA. The cells and circuitry for itch responses in mice. Science. 2013;340(6135):968–71.
Liu XY, et al. B-type natriuretic peptide is neither itch-specific nor functions upstream of the GRP-GRPR signaling pathway. Mol Pain. 2014;10:4.
Petrofsky JS, et al. The interrelationship between air temperature and humidity as applied locally to the skin: the resultant response on skin temperature and blood flow with age differences. Med Sci Monit. 2012;18(4):CR201–8.
Petrofsky J, et al. The effect of moist air on skin blood flow and temperature in subjects with and without diabetes. Diabetes Technol Ther. 2012;14(2):105–16.
McLellan K, et al. The influence of environmental temperature on the response of the skin to local pressure: the impact of aging and diabetes. Diabetes Technol Ther. 2009;11(12):791–8.
Petrofsky J. A method of measuring the interaction between skin temperature and humidity on skin vascular endothelial function in people with diabetes. J Med Eng Technol. 2011;35(6–7):330–7.
Akiyama T, Carstens MI, Carstens E. Enhanced scratching evoked by PAR-2 agonist and 5-HT but not histamine in a mouse model of chronic dry skin itch. Pain. 2010;151(2):378–83.
Akiyama T, Carstens MI, Carstens E. Spontaneous itch in the absence of hyperalgesia in a mouse hindpaw dry skin model. Neurosci Lett. 2010;484(1):62–5.
Yoshioka T, et al. Impact of the Gly573Ser substitution in TRPV3 on the development of allergic and pruritic dermatitis in mice. J Invest Dermatol. 2009;129(3):714–22.
Sun YG, Chen ZF. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature. 2007;448(7154):700–3.
Zhao ZQ, et al. Descending control of itch transmission by the serotonergic system via 5-HT1A-facilitated GRP-GRPR signaling. Neuron. 2014;84(4):821–34.
Schmelz M, et al. Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J Neurophysiol. 2003;89(5):2441–8.
Akiyama T, Carstens MI, Carstens E. Facial injections of pruritogens and algogens excite partly overlapping populations of primary and second-order trigeminal neurons in mice. J Neurophysiol. 2010;104(5):2442–50.
Sommer C. Serotonin in pain and analgesia: actions in the periphery. Mol Neurobiol. 2004;30(2):117–25.
Bockaert J, et al. Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation. Cell Tissue Res. 2006;326(2):553–72.
Haruna T, et al. S-777469, a novel cannabinoid type 2 receptor agonist, suppresses itch-associated scratching behavior in rodents through inhibition of itch signal transmission. Pharmacology. 2015;95(1–2):95–103.
Dillon SR, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol. 2004;5(7):752–60.
Neis MM, et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol. 2006;118(4):930–7.
Szegedi K, et al. Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin. Exp Dermatol. 2012;21(6):431–6.
Takaoka A, et al. Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis. Eur J Pharmacol. 2005;516(2):180–1.
Yosipovitch G, Papoiu AD. What causes itch in atopic dermatitis? Curr Allergy Asthma Rep. 2008;8(4):306–11.
Toyoda M, et al. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol. 2002;147(1):71–9.
Haas S, et al. Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis. J Dermatol Sci. 2010;58(3):193–7.
Ohmura T, et al. Involvement of substance P in scratching behaviour in an atopic dermatitis model. Eur J Pharmacol. 2004;491(2–3):191–4.
Sowunmi A, Walker O, Salako LA. Pruritus and antimalarial drugs in Africans. Lancet. 1989;2(8656):213.
Guan Y, et al. Mas-related G-protein-coupled receptors inhibit pathological pain in mice. Proc Natl Acad Sci U S A. 2010;107(36):15933–8.
Fleischer Jr AB. Pruritus in the elderly: management by senior dermatologists. J Am Acad Dermatol. 1993;28(4):603–9.
Duque MI, et al. Uremic pruritus is associated with higher kt/V and serum calcium concentration. Clin Nephrol. 2006;66(3):184–91.
Patel TS, Freedman BI, Yosipovitch G. An update on pruritus associated with CKD. Am J Kidney Dis. 2007;50(1):11–20.
Ward L, Wright E, McMahon SB. A comparison of the effects of noxious and innocuous counter stimuli on experimentally induced itch and pain. Pain. 1996;64(1):129–38.
Yosipovitch G, et al. Scratching and noxious heat stimuli inhibit itch in humans: a psychophysical study. Br J Dermatol. 2007;156(4):629–34.
van Os-Medendorp H, et al. Prevalence and predictors of psychosocial morbidity in patients with chronic pruritic skin diseases. J Eur Acad Dermatol Venereol. 2006;20(7):810–7.
Weiner AA, Sheehan DV. Etiology of dental anxiety: psychological trauma or CNS chemical imbalance? Gen Dent. 1990;38(1):39–43.
Harlow D, et al. Impaired quality of life of adults with skin disease in primary care. Br J Dermatol. 2000;143(5):979–82.
Yosipovitch G, et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143(5):969–73.
Petrofsky JS. Resting blood flow in the skin: does it exist, and what is the influence of temperature, aging, and diabetes? J Diabetes Sci Technol. 2012;6(3):674–85.
Petrofsky JS, et al. The effect of body fat, aging, and diabetes on vertical and shear pressure in and under a waist belt and its effect on skin blood flow. Diabetes Technol Ther. 2010;12(2):153–60.
Petrofsky J, Lee S. The effects of type 2 diabetes and aging on vascular endothelial and autonomic function. Med Sci Monit. 2005;11(6):CR247–54.
Petrofsky J, et al. The interrelationship between locally applied heat, ageing and skin blood flow on heat transfer into and from the skin. J Med Eng Technol. 2011;35(5):262–74.
Petrofsky JS, et al. Sweat production during global heating and during isometric exercise in people with diabetes. Med Sci Monit. 2005;11(11):CR515–21.
Gubbels Bupp MR. Sex, the aging immune system, and chronic disease. Cell Immunol. 2015;294(2):102–10.
Bonomini F, Rodella LF, Rezzani R. Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis. 2015;6(2):109–20.
Edd SN, Giori NJ, Andriacchi TP. The role of inflammation in the initiation of osteoarthritis after meniscal damage. J Biomech. 2015;48:1420–6.
Bessueille L, Magne D. Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes. Cell Mol Life Sci. 2015;72:2475–89.
Stangier U, Ehlers A, Gieler U. Predicting long-term outcome in group treatment of atopic dermatitis. Psychother Psychosom. 2004;73(5):293–301.
Dykes PJ, Marks R. An appraisal of the methods used in the assessment of atrophy from topical corticosteroids. Br J Dermatol. 1979;101(5):599–609.
Stander S, et al. Treatment of pruritic diseases with topical calcineurin inhibitors. Ther Clin Risk Manag. 2006;2(2):213–8.
Patel T, Ishiuji Y, Yosipovitch G. Menthol: a refreshing look at this ancient compound. J Am Acad Dermatol. 2007;57(5):873–8.
Papoiu AD, Yosipovitch G. Topical capsaicin. The fire of a ‘hot’ medicine is reignited. Expert Opin Pharmacother. 2010;11(8):1359–71.
Wood GJ, et al. An insatiable itch. J Pain. 2009;10(8):792–7.
Imamachi N, et al. TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms. Proc Natl Acad Sci U S A. 2009;106(27):11330–5.
Freitag G, Hoppner T. Results of a postmarketing drug monitoring survey with a polidocanol-urea preparation for dry, itching skin. Curr Med Res Opin. 1997;13(9):529–37.
Yosipovitch G, et al. The effect of topically applied aspirin on localized circumscribed neurodermatitis. J Am Acad Dermatol. 2001;45(6):910–3.
Andoh T, et al. Thromboxane A2 induces itch-associated responses through TP receptors in the skin in mice. J Invest Dermatol. 2007;127(8):2042–7.
Szepietowski JC, Szepietowski T, Reich A. Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study. Acta Dermatovenerol Croat. 2005;13(2):97–103.
Bergasa NV, et al. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. J Am Acad Dermatol. 1999;41(3 Pt 1):431–4.
Davis MP, et al. Mirtazapine for pruritus. J Pain Symptom Manage. 2003;25(3):288–91.
Stander S, et al. Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study. Acta Derm Venereol. 2009;89(1):45–51.
Yosipovitch G, Carstens E, McGlone F. Chronic itch and chronic pain: analogous mechanisms. Pain. 2007;131(1–2):4–7.
Hundley JL, Yosipovitch G. Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study. J Am Acad Dermatol. 2004;50(6):889–91.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Petrofsky, J.S. (2015). Skin Itch in the Elderly. In: Farage, M., Miller, K., Maibach, H. (eds) Textbook of Aging Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27814-3_126-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-27814-3_126-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27814-3
eBook Packages: Springer Reference MedicineReference Module Medicine